Kazuo Yamada

8.3k total citations
242 papers, 5.9k citations indexed

About

Kazuo Yamada is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Kazuo Yamada has authored 242 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Cellular and Molecular Neuroscience, 90 papers in Molecular Biology and 47 papers in Cognitive Neuroscience. Recurrent topics in Kazuo Yamada's work include Neuroscience and Neuropharmacology Research (38 papers), Memory and Neural Mechanisms (28 papers) and Genetics and Neurodevelopmental Disorders (24 papers). Kazuo Yamada is often cited by papers focused on Neuroscience and Neuropharmacology Research (38 papers), Memory and Neural Mechanisms (28 papers) and Genetics and Neurodevelopmental Disorders (24 papers). Kazuo Yamada collaborates with scholars based in Japan, United States and Poland. Kazuo Yamada's co-authors include Takeo Yoshikawa, Tomoko Toyota, Tatsuya Matsura, Shigenobu Kanba, Yoshimi Iwayama, Yukio Ichitani, Yumiko Inoue, Tõru Hayakawa, Tadafumi Kato and Mitsuhito Mase and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Kazuo Yamada

234 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuo Yamada Japan 42 2.5k 1.5k 978 728 534 242 5.9k
H. Ronald Zielke United States 30 2.2k 0.9× 1.6k 1.0× 609 0.6× 366 0.5× 423 0.8× 69 4.6k
Robert H. Lipsky United States 44 2.6k 1.0× 2.5k 1.6× 806 0.8× 970 1.3× 962 1.8× 112 8.1k
Takeshi Hashimoto Japan 35 2.6k 1.0× 1.7k 1.1× 364 0.4× 474 0.7× 401 0.8× 188 5.1k
Heide Hörtnagl Austria 49 2.3k 0.9× 2.7k 1.8× 409 0.4× 542 0.7× 438 0.8× 127 7.8k
Norio Mori Japan 43 2.1k 0.8× 2.1k 1.4× 1.5k 1.5× 2.1k 2.9× 1.1k 2.1× 172 7.1k
Rosalinda C. Roberts United States 47 2.7k 1.1× 3.5k 2.3× 510 0.5× 1.1k 1.5× 1.1k 2.0× 139 7.6k
Anat Biegon United States 55 2.2k 0.9× 3.5k 2.3× 616 0.6× 1.1k 1.5× 806 1.5× 187 8.4k
Mark S. Sonders United States 24 2.5k 1.0× 3.2k 2.1× 379 0.4× 680 0.9× 358 0.7× 32 5.3k
Carolyn Beebe Smith United States 34 1.8k 0.7× 1.3k 0.8× 1.2k 1.2× 1.4k 1.9× 266 0.5× 100 4.4k
Andrea Schmitt Germany 48 3.3k 1.3× 1.4k 0.9× 1.0k 1.1× 1.1k 1.4× 1.8k 3.4× 254 8.6k

Countries citing papers authored by Kazuo Yamada

Since Specialization
Citations

This map shows the geographic impact of Kazuo Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Yamada more than expected).

Fields of papers citing papers by Kazuo Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Yamada. The network helps show where Kazuo Yamada may publish in the future.

Co-authorship network of co-authors of Kazuo Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Yamada. A scholar is included among the top collaborators of Kazuo Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Yamada. Kazuo Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujihara, Kazuyuki, Kazuo Yamada, Yukio Ichitani, et al.. (2020). CRISPR/Cas9-engineered Gad1 elimination in rats leads to complex behavioral changes: implications for schizophrenia. Translational Psychiatry. 10(1). 426–426. 20 indexed citations
2.
Horimoto, Yoshihiko, Yoshihiro Ito, Akihiko Iida, et al.. (2020). Dopaminergic function in spinocerebellar ataxia type 6 patients with and without parkinsonism. Journal of Neurology. 267(9). 2692–2696. 5 indexed citations
3.
Fujihara, Junko, Kaori Kimura, Ken‐ichi Inoue, et al.. (2019). Lack of Association of a Single Nucleotide Polymorphism (rs1053874)in the DNase I Gene With Plural Tissue Weight. 35(2). 37–42.
6.
Kusumoto, Chiaki, et al.. (2010). Protection by Exogenously Added Coenzyme Q9 against Free Radical-Induced Injuries in Human Liver Cells. Journal of Clinical Biochemistry and Nutrition. 46(3). 244–251. 6 indexed citations
7.
Ohta, Yoshiji, Yoichiro Imai, Tatsuya Matsura, Akira Kitagawa, & Kazuo Yamada. (2005). Preventive effect of neutropenia on carbon tetrachloride‐induced hepatotoxicity in rats. Journal of Applied Toxicology. 26(2). 178–186. 27 indexed citations
8.
Ide, Masayuki, Kazuo Yamada, Tomoko Toyota, et al.. (2005). Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: evidence for association of ASCL1 with Parkinson’s disease. Human Genetics. 117(6). 520–527. 23 indexed citations
9.
Aoki, Mika, Kazuo Yamada, Yoshimi Iwayama‐Shigeno, et al.. (2004). Case-control association study of human netrin G1 gene in Japanese schizophrenia.. PubMed. 51(2). 121–8. 12 indexed citations
10.
Yamada, Kazuo, Gohei Yagi, & Shigenobu Kanba. (2003). Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: A randomized controlled trial. Psychiatry and Clinical Neurosciences. 57(2). 183–187. 13 indexed citations
11.
Aihara, Noritaka, Kazuo Yamada, & Hitoo Nishino. (2002). [Neural transplantation for cerebral ischemia/infarction--the present situation and prospects].. PubMed. 60(2). 411–8. 1 indexed citations
12.
13.
Yamada, Kazuo, Akira Kinoshita, Eiji Kohmura, et al.. (1992). Detection and partial purification of ischaemia-related neurotrophic activity in the periinfarcted brain tissue. Neurological Research. 14(3). 267–272. 2 indexed citations
14.
Fukiyama, Koshiro, Osamu Iimura, KAORU YOSHINAGA, et al.. (1991). A double-blind comparative study of doxazosin and prazosin in the treatment of essential hypertension. American Heart Journal. 121(1). 317–322. 8 indexed citations
15.
Saito, Aki, Reiko Shiba, Masashi Yanagisawa, et al.. (1991). Characterization of the Effect of Endothelins in Canine Cerebral Arteries. Journal of Cardiovascular Pharmacology. 17. S219–221. 1 indexed citations
16.
Kudo, Yoshiki, et al.. (1989). Characterization of amino-acid transport systems in guinea-pig intestinal brush-border membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 985(2). 120–126. 26 indexed citations
17.
Toyama, Junji, et al.. (1988). Diverse characteristics in potential waveform of his-purkinje system - Experimental and simulation studies.. Japanese Circulation Journal. 52(2). 188–196. 3 indexed citations
18.
Osaka, Toshiyuki, Naoya Tsuboi, Itsuo Kodama, Junji Toyama, & Kazuo Yamada. (1987). -P247- EFFECTS OF ACTIVATION SEQUENCES AND ANISOTROPIC CELLULAR GEOMETRY ON THE REPOLARIZATION PHASE OF ACTION POTENTIALS OF DOG VENTRICULAR MUSCLES. Japanese Circulation Journal-english Edition. 51(8). 963–964. 1 indexed citations
19.
Kodama, I., et al.. (1978). Effects of l-penbutolol (Hoe 893d) on the transmembrane potentials of canine purkinje fibers and ventricular muscle fibers.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 231(2). 232–42. 5 indexed citations
20.
Okada, Hiroshi, Kunio Aoki, Hiroshi Horibe, et al.. (1967). A Study of Subjective Symptoms of Arteriosclerosis in a Population. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 4(5). 246–256. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026